- Published on
KembaraXtra – Medicine – Monoamine Oxidase Inhibitor (MAOI) Poisoning
Monoamine oxidase inhibitors are medications primarily used in the treatment of depression. Selegiline, a selective monoamine oxidase-B inhibitor, is also used in Parkinson disease and is available in oral and transdermal formulations. MAOIs disrupt the normal balance between monoamine synthesis and degradation, leading to increased neural norepinephrine levels, receptor downregulation, and irreversible inhibition of monoamine oxidase enzymes. Monoamine oxidase is the principal enzyme responsible for inactivation of bioactive amines. MAO-A is found predominantly in the gut and liver and protects against dietary amines, whereas MAO-B is present in neuronal terminals and platelets.
The toxicology of MAOI overdose is complex and incompletely understood. Many MAOIs have amphetamine-like structures and initially produce indirect sympathomimetic effects, followed later by a sympatholytic phase that may result in hypotension. A classic and dangerous complication is the MAOI hypertensive crisis syndrome, caused by impaired degradation of norepinephrine with sudden release triggered by indirect- or mixed-acting sympathomimetics. Common precipitants include tyramine-rich foods, cocaine, and amphetamines. Another major complication is serotonin syndrome, which results from excessive serotonergic activity, often due to drug interactions involving MAOIs combined with agents that increase serotonin synthesis, release, reuptake inhibition, receptor stimulation, or decrease serotonin metabolism.
Clinical presentation of MAOI overdose is often delayed, typically occurring 6–12 hours after ingestion. Early manifestations commonly include hypertension and severe headache, followed by hyperadrenergic features such as tachycardia, agitation, mydriasis, and neuromuscular excitation. Patients may develop tremor, hyperreflexia, myoclonus, rigidity, seizures, and marked hyperthermia. Severe toxicity may lead to rhabdomyolysis, acute renal failure, disseminated intravascular coagulation, and acute respiratory distress syndrome. In hypertensive crisis syndromes, patients may present with occipital headache, altered mental status, intracranial hemorrhage, and seizures. Serotonin syndrome is characterized by neuromuscular hyperactivity, autonomic instability, and altered mental status, with rapid onset over hours, distinguishing it from neuroleptic malignant syndrome.
History should focus on timing and quantity of ingestion, access to pill bottles, intent (accidental versus intentional), and possible co-ingestants. Physical examination often reveals neuromuscular hyperactivity, autonomic instability, and changes in mental status. Continuous blood pressure, cardiac, and temperature monitoring is essential due to the risk of rapid deterioration.
Laboratory evaluation should include electrolytes, renal function, glucose, creatine kinase, urinalysis for myoglobin, coagulation studies, and arterial blood gas analysis in severe cases. Urine toxicology screening may show amphetamine positivity because of structural similarities. Imaging such as chest radiography is indicated if respiratory complications are suspected, and head CT is warranted for severe headache, focal neurologic findings, or altered mental status. Lumbar puncture may be required when meningitis or subarachnoid hemorrhage remains a concern.
Management begins with aggressive supportive care focused on airway, breathing, and circulation. Early IV access, oxygen, and cardiac monitoring are mandatory. Activated charcoal may be administered if the patient presents early and the airway is protected. Hyperthermia should be treated promptly with benzodiazepines for agitation and active cooling measures. Severe muscle rigidity and persistent hyperthermia may require paralysis with nondepolarizing neuromuscular blockers and mechanical ventilation. Hypertensive emergencies are treated with short-acting, titratable intravenous agents such as nitroprusside, while hypotension is managed initially with isotonic fluids and, if needed, norepinephrine. Seizures are treated with benzodiazepines, followed by barbiturates if refractory. Rhabdomyolysis requires aggressive IV hydration to preserve renal function.
Serotonin syndrome management centers on immediate discontinuation of offending agents and supportive care. Cyproheptadine, a nonselective serotonin antagonist, may be used in moderate to severe cases. Importantly, phentolamine is contraindicated in MAOI overdose due to the risk of unopposed beta-adrenergic stimulation.
All patients with suspected MAOI overdose require hospital admission to a monitored setting for at least 24 hours because of delayed toxicity. Intensive care admission is indicated for patients with severe hyperthermia, seizures, hemodynamic instability, or end-organ failure. Patients with resolved mild hypertensive or serotonin syndromes may be considered for discharge after prolonged emergency department observation. Intentional ingestions require psychiatric evaluation prior to discharge.
Key clinical pitfalls include underestimating the delayed onset of toxicity, failure to recognize drug-drug or food interactions, and inappropriate use of contraindicated antihypertensive agents. Linezolid and methylene blue should also be recognized as MAOI-like agents capable of precipitating similar toxic syndromes.
Monoamine oxidase inhibitors are medications primarily used in the treatment of depression. Selegiline, a selective monoamine oxidase-B inhibitor, is also used in Parkinson disease and is available in oral and transdermal formulations. MAOIs disrupt the normal balance between monoamine synthesis and degradation, leading to increased neural norepinephrine levels, receptor downregulation, and irreversible inhibition of monoamine oxidase enzymes. Monoamine oxidase is the principal enzyme responsible for inactivation of bioactive amines. MAO-A is found predominantly in the gut and liver and protects against dietary amines, whereas MAO-B is present in neuronal terminals and platelets.
The toxicology of MAOI overdose is complex and incompletely understood. Many MAOIs have amphetamine-like structures and initially produce indirect sympathomimetic effects, followed later by a sympatholytic phase that may result in hypotension. A classic and dangerous complication is the MAOI hypertensive crisis syndrome, caused by impaired degradation of norepinephrine with sudden release triggered by indirect- or mixed-acting sympathomimetics. Common precipitants include tyramine-rich foods, cocaine, and amphetamines. Another major complication is serotonin syndrome, which results from excessive serotonergic activity, often due to drug interactions involving MAOIs combined with agents that increase serotonin synthesis, release, reuptake inhibition, receptor stimulation, or decrease serotonin metabolism.
Clinical presentation of MAOI overdose is often delayed, typically occurring 6–12 hours after ingestion. Early manifestations commonly include hypertension and severe headache, followed by hyperadrenergic features such as tachycardia, agitation, mydriasis, and neuromuscular excitation. Patients may develop tremor, hyperreflexia, myoclonus, rigidity, seizures, and marked hyperthermia. Severe toxicity may lead to rhabdomyolysis, acute renal failure, disseminated intravascular coagulation, and acute respiratory distress syndrome. In hypertensive crisis syndromes, patients may present with occipital headache, altered mental status, intracranial hemorrhage, and seizures. Serotonin syndrome is characterized by neuromuscular hyperactivity, autonomic instability, and altered mental status, with rapid onset over hours, distinguishing it from neuroleptic malignant syndrome.
History should focus on timing and quantity of ingestion, access to pill bottles, intent (accidental versus intentional), and possible co-ingestants. Physical examination often reveals neuromuscular hyperactivity, autonomic instability, and changes in mental status. Continuous blood pressure, cardiac, and temperature monitoring is essential due to the risk of rapid deterioration.
Laboratory evaluation should include electrolytes, renal function, glucose, creatine kinase, urinalysis for myoglobin, coagulation studies, and arterial blood gas analysis in severe cases. Urine toxicology screening may show amphetamine positivity because of structural similarities. Imaging such as chest radiography is indicated if respiratory complications are suspected, and head CT is warranted for severe headache, focal neurologic findings, or altered mental status. Lumbar puncture may be required when meningitis or subarachnoid hemorrhage remains a concern.
Management begins with aggressive supportive care focused on airway, breathing, and circulation. Early IV access, oxygen, and cardiac monitoring are mandatory. Activated charcoal may be administered if the patient presents early and the airway is protected. Hyperthermia should be treated promptly with benzodiazepines for agitation and active cooling measures. Severe muscle rigidity and persistent hyperthermia may require paralysis with nondepolarizing neuromuscular blockers and mechanical ventilation. Hypertensive emergencies are treated with short-acting, titratable intravenous agents such as nitroprusside, while hypotension is managed initially with isotonic fluids and, if needed, norepinephrine. Seizures are treated with benzodiazepines, followed by barbiturates if refractory. Rhabdomyolysis requires aggressive IV hydration to preserve renal function.
Serotonin syndrome management centers on immediate discontinuation of offending agents and supportive care. Cyproheptadine, a nonselective serotonin antagonist, may be used in moderate to severe cases. Importantly, phentolamine is contraindicated in MAOI overdose due to the risk of unopposed beta-adrenergic stimulation.
All patients with suspected MAOI overdose require hospital admission to a monitored setting for at least 24 hours because of delayed toxicity. Intensive care admission is indicated for patients with severe hyperthermia, seizures, hemodynamic instability, or end-organ failure. Patients with resolved mild hypertensive or serotonin syndromes may be considered for discharge after prolonged emergency department observation. Intentional ingestions require psychiatric evaluation prior to discharge.
Key clinical pitfalls include underestimating the delayed onset of toxicity, failure to recognize drug-drug or food interactions, and inappropriate use of contraindicated antihypertensive agents. Linezolid and methylene blue should also be recognized as MAOI-like agents capable of precipitating similar toxic syndromes.
0 Comments
